© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
Understanding Further Treatment Opportunities for Patients With Polycythemia Vera
Pharmacy Times® interviewed Brady Stein, MD, MHSc, of the Feinberg School of Medicine at Northwestern University, on the implications of the results of his research on further investigation and treatment opportunities for patients with polycythemia vera.
Pharmacy Times® interviewed Brady Stein, an associate professor of medicine in hematology and oncology at the Feinberg School of Medicine at Northwestern University, on his presentation at the 62nd ASH Annual Meeting and Exposition. The presentation discusses a multicenter, noninterventional, prospective observational study of patients with polycythemia vera (PV) in US clinical practices, specifically in relation to mortality and causes of death.
In this video, Stein explains the implications of the study results on further investigation and treatment opportunities for patients with PV.
